Stem Cell Study Shows Early Promise for MS

Stem Cell Study Shows Early Promise for MS

By Maureen Martino A University of Bristol study has demonstrated that stem cell therapy could slow the progression of multiple sclerosis, lending hope to patients with the disease. In the trial, six MS subjects were injected with their own PCT stem cells collected from their bone marrow. Researchers then injected the stem cells into each patient’s blood stream. Results from …

Test Could ID Who Should Get MS Drugs

By Tracey Staton In another potential step toward personalized medicine, researchers have developed a test that predicts whether multiple sclerosis patients will respond to beta interferon drugs. The $6 billion drug class–which includes Biogen Idec’s Avonex, Merck KGaA’s Rebif, and Bayer’s Betaferon–works in patients with one subtype of MS, but not in the other, researchers …